home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Using Real-World Evidence To Enhance Drug Development: Arterial Health Monitoring Innovations

 
  October 29, 2024  
     
 
Xtalks, Online
2024-12-02


As the pharmaceutical industry increasingly turns to real-world evidence to support drug development and regulatory decisions, the importance of accurate and comprehensive health monitoring cannot be overstated.

Arterial health is a key determinant of the effectiveness and safety of many therapies, particularly in the context of cardiovascular disease, diabetes and other chronic conditions. Central blood pressure and arterial stiffness serve as robust biomarkers for assessing the impact of new drugs on the vascular system, providing insights that traditional peripheral measurements cannot offer.

CONNEQT Pulse empowers pharmaceutical companies to collect precise RWE, facilitating more informed decisions in the drug development process from early-phase trials to post-market surveillance.

It is a cuff-based device that monitors arterial health through central blood pressure and pulse wave analysis (PWA), thus representing a significant advancement in this area. This webinar will explore how CONNEQT Pulse can be integrated into clinical trials and real-world studies to generate critical RWE that informs drug efficacy and safety profiles.

This webinar will provide a detailed look at the application of CONNEQT Pulse in drug development, its validation as a clinical tool and its potential to improve therapeutic outcomes through better-informed regulatory strategies.

Register for this webinar to discover how gathering real-world evidence can revolutionize drug development for cardiovascular diseases.

Keywords: Cardiovascular Disease, Drug Development, Clinical Research, Biomarkers, Real-World Evidence, Clinical Data, Regulatory, Therapeutic Areas, RWE, Commercialization/HEOR/Market Access
 
 
Organized by: Xtalks
Invited Speakers: Dr. Sanjeev Bhavnani, MD, FACC, Senior Cardiologist and Principal Investigator/AI Trials - Scripps Clinic; Former Senior Medical Officer of Digital Health - US FDA
 
Deadline for Abstracts: 2024-12-02
 
Registration: Free Registration
E-mail: tristan@xtalks.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.